Hepapar Liquid
NDC Package 44911-0516-1
Package Information
Hepapar (carduus marianus, chelidonium majus, taraxacum officinale, boldo, hepar suis, lycopodium clavatum, mercurius solubilis, natrum sulphuricum, nux vomica, phosphorus, chenopodium anthelminticum) liquids May temporarily relieve abdominal bloating and soreness and constipation alternating with diarrhea.**Claims based on traditional homeopathic practice, not accepted medical evidence. This formulation utilizes a liquid delivery system. Marketed by Energique, Inc., this product is identified by NDC 44911-0516.
Identification & Billing
Clinical Specifications
- CHELIDONIUM MAJUS WHOLE 3 [hp_X]/mL
- DYSPHANIA AMBROSIOIDES WHOLE 16 [hp_X]/mL
- LYCOPODIUM CLAVATUM SPORE 12 [hp_X]/mL
- MERCURIUS SOLUBILIS 12 [hp_X]/mL
- MILK THISTLE 3 [hp_X]/mL
- PEUMUS BOLDUS LEAF 6 [hp_X]/mL
- PHOSPHORUS 12 [hp_X]/mL
- PORK LIVER 6 [hp_X]/mL
- SODIUM SULFATE 12 [hp_X]/mL
- STRYCHNOS NUX-VOMICA SEED 12 [hp_X]/mL
- TARAXACUM OFFICINALE 3 [hp_X]/mL
- Allergens - [CS]
- Cell-mediated Immunity - [PE] (Physiologic Effect)
- Increased Histamine Release - [PE] (Physiologic Effect)
- Increased IgG Production - [PE] (Physiologic Effect)
- Non-Standardized Plant Allergenic Extract - [EPC] (Established Pharmacologic Class)
- Plant Proteins - [CS]
- Seed Storage Proteins - [CS]
Regulatory & Marketing
Hierarchy Structure
- 44911 - Energique, Inc.
- 44911-0516 - Hepapar
- 44911-0516-1 - 30 mL in 1 BOTTLE, DROPPER
- 44911-0516 - Hepapar
The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.
* Please review the full disclaimer at the bottom of this page.
Frequently Asked Questions
What is the distribution configuration for this product package?
The code 44911-0516-1 identifies a specific commercial package of 30 ml in 1 bottle, dropper of Hepapar, a human over the counter drug labeled by Energique, Inc.. This liquid is formulated for oral use and contains chelidonium majus whole; dysphania ambrosioides whole; lycopodium clavatum spore; mercurius solubilis; milk thistle; peumus boldus leaf; phosphorus; pork liver; sodium sulfate; strychnos nux-vomica seed; taraxacum officinale as the active substance.
Is this product currently listed with the FDA?
Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Energique, Inc. on October 25, 2019.
How is this Energique, Inc. product billed for insurance claims?
For medical billing and reimbursement, this package follows the 11-digit CMS format: 44911051601. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.
11-Digit Code Conversion
Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:
Note: The zero is added to the Package segment to maintain the 5-4-2 structure.